Page last updated: 2024-09-03

imatinib mesylate and Thoracic Neoplasms

imatinib mesylate has been researched along with Thoracic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, S; Dimitrakopoulou-Strauss, A; Gruenwald, V; Haller, F; Hohenberger, P; Kasper, B; Limprecht, R; Pilz, L; Rauch, G; Reichardt, P; Sommer, M1
Cheng, JW; Hou, YY; Lu, SH; Tan, YS; Wang, H; Xu, ST; Zheng, RH1
De Pennington, N; Fearnhead, N; Maynard, ND; Sujendran, V; Warren, BF1

Trials

1 trial(s) available for imatinib mesylate and Thoracic Neoplasms

ArticleYear
Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 76

    Topics: Abdominal Neoplasms; Abdominal Wall; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Extremities; Female; Fibromatosis, Aggressive; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Pyrimidines; Response Evaluation Criteria in Solid Tumors; Retroperitoneal Neoplasms; Soft Tissue Neoplasms; Thoracic Neoplasms; Thoracic Wall; Treatment Outcome; Young Adult

2017

Other Studies

2 other study(ies) available for imatinib mesylate and Thoracic Neoplasms

ArticleYear
Primary thoracic cavity gastrointestinal stromal tumor.
    The Journal of thoracic and cardiovascular surgery, 2010, Volume: 140, Issue:2

    Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; DNA Mutational Analysis; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Reoperation; Thoracic Neoplasms; Thoracotomy; Tomography, X-Ray Computed; Treatment Outcome

2010
Proposals for the management of gastrointestinal stromal tumours of the stomach.
    The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2007, Volume: 5, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Disease-Free Survival; Female; Follow-Up Studies; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatectomy; Piperazines; Population Surveillance; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrimidines; Splenectomy; Stomach Neoplasms; Thoracic Neoplasms; Thoracic Wall; Treatment Outcome

2007